GlassScriptPhysician profile
Karen S Sable
NPI 1316949738
$300.69
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $45.24 · 2021: $116.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $175.05 | 2019-2021 | |
| Abbvie INC. | $38.98 | 2019 | |
| Ucb, INC. | $16.44 | 2019 | |
| Allergan, INC. | $15.68 | 2019 | |
| Nestle Healthcare Nutrition INC. | $15.13 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.72 | 2020 | |
| Qol Medical, LLC | $12.63 | 2019 | |
| Romark Laboratories, Lc | $12.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Sable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.